Lam, Thua-Phong, Tran, Ngoc-Vi Nguyen, Pham, Long-Hung Dinh, Lai, Nghia Vo-Trong, Dang, Bao-Tran Ngoc, Truong, Ngoc-Lam Nguyen, Nguyen-Vo, Song-Ky, Hoang, Thuy-Linh, Mai, Tan Thanh, Tran, Thanh-Dao, Lam, Thua-Phong, Tran, Ngoc-Vi Nguyen, Pham, Long-Hung Dinh, Lai, Nghia Vo-Trong, Dang, Bao-Tran Ngoc, Truong, Ngoc-Lam Nguyen, Nguyen-Vo, Song-Ky, Hoang, Thuy-Linh, Mai, Tan Thanh, and Tran, Thanh-Dao
Diabetes mellitus remains a major global health issue, and great attention is directed at natural therapeutics. This systematic review aimed to assess the potential of flavonoids as antidiabetic agents by investigating their inhibitory effects on alpha-glucosidase and alpha-amylase, two key enzymes involved in starch digestion. Six scientific databases (PubMed, Virtual Health Library, EMBASE, SCOPUS, Web of Science, and WHO Global Index Medicus) were searched until August 21, 2022, for in vitro studies reporting IC50 values of purified flavonoids on alpha-amylase and alpha-glucosidase, along with corresponding data for acarbose as a positive control. A total of 339 eligible articles were analyzed, resulting in the retrieval of 1643 flavonoid structures. These structures were rigorously standardized and curated, yielding 974 unique compounds, among which 177 flavonoids exhibited inhibition of both alpha-glucosidase and alpha-amylase are presented. Quality assessment utilizing a modified CONSORT checklist and structure-activity relationship (SAR) analysis were performed, revealing crucial features for the simultaneous inhibition of flavonoids against both enzymes. Moreover, the review also addressed several limitations in the current research landscape and proposed potential solutions. The curated datasets are available online at https://github.com/MedChemUMP/FDIGA.